REGN Operating Cash Flow (Statement)

Regeneron Pharmaceuticals · Operating Cash Flow (Statement)

REGN logo

REGN Operating Cash Flow (Statement)

Latest reported$574.50M
REGN Quarterly Cash from Operations (-$2.70M → $574.50M)
High-resolution chart · PNG

REGN operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
574,500,000
1,078,900,000
1,170,700,000
1,618,700,000
1,144,400,000
1,045,100,000
1,262,800,000
1,291,200,000
354,000,000
1,512,500,000
1,089,700,000
1,114,300,000
1,022,400,000
1,367,600,000
1,719,900,000
628,900,000
564,400,000
2,101,700,000
2,372,500,000
3,413,600,000
626,700,000
668,500,000
1,231,000,000
-254,300,000
943,400,000
698,000,000
787,400,000
557,300,000
188,300,000
897,000,000
728,800,000
452,900,000
394,600,000
618,800,000
566,937,000
414,832,000
-30,570,000
355,901,000
377,879,000
651,029,000
399,499,000
44,989,000
281,823,000
892,853,000
257,831,000
-101,727,000
198,175,000
164,321,000
336,412,000
53,527,000
276,781,000
92,455,000
128,164,000
86,248,000
93,185,000
-2,382,000
-78,377,000
-87,041,000
-50,317,000
-46,735,000
-34,050,000
-10,580,000
-41,699,000
160,669,000
-12,625,000
-10,001,000
-46,404,000
-9,822,000
-5,805,000
-10,199,000
-35,840,000
-41,546,000
6,197,000
-17,897,000
50,817,000
-10,700,000
-3,507,000
-9,238,000
53,303,000
-14,831,000
-20,675,000
5,278,000
-19,847,000
-14,998,000
-28,583,000
33,132,000
-12,199,000
-3,586,000
17,458,000
-18,582,000
-28,429,000
61,810,000
-40,707,000
1,193,000
-31,026,000
-23,854,000
-29,589,000
-26,054,000
-17,654,000
-21,891,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.